Immutep Limited - ADR

NASDAQ:IMMP  
2.25
+0.05 (+2.27%)
7:15:12 PM EDT: $2.36 +0.11 (+4.89%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Immutep Limited - ADR Stock, NASDAQ:IMMP

Australia Square, 264 George Street, Sydney, New South Wales (NSW) 2000
Australia
Phone: +61.2.8315.7003
Number of Employees:
http://www.immutep.com

Description

Immutep Ltd. is a clinical stage biotechnology company, which engages in the development of LAG-3 related immunotherapeutic products for cancer and autoimmune diseases. Its products include eftilagimod alpha (IMP321), IMP761, leramilimab (IMP701), and GSK�781 (IMP731). The company was founded on May 21, 1987, and is headquartered in Sydney, Australia.